Do Relaxin Levels Impact Hip Injury Incidence in Women? A Scoping Review
- PMID: 35185802
- PMCID: PMC8855110
- DOI: 10.3389/fendo.2022.827512
Do Relaxin Levels Impact Hip Injury Incidence in Women? A Scoping Review
Abstract
Purpose: The aim of this review is to assess the current evidence regarding the impact of relaxin on incidence of soft tissue hip injuries in women.
Methods: A trained research librarian assisted with searches of PubMed, Embase, CINAHL, and SPORTDiscus, with a preset English language filter. The review was completed per the Joanna Briggs Institute (JBI) Manual for Evidence Synthesis methodology. Included studies required assessment of relaxin effects on musculoskeletal health, pelvic girdle stability, or hip joint structures in human subjects. Letters, texts, and opinion papers were excluded.
Results: Our screen yielded 82 studies. Molecularly, relaxin activates matrix metalloproteinases (MMPs) including collagenases MMP-1/-13 and gelatinases MMP-2/-9 to loosen pelvic ligaments for parturition. However, relaxin receptors have also been detected in female periarticular tissues, such as the anterior cruciate ligament, which tears significantly more often during the menstrual cycle peak of relaxin. Recently, high concentrations of relaxin-activated MMP-9 receptors have been found on the acetabular labrum; their expression upregulated by estrogen.
Conclusions: Menstrual cycle peaks of relaxin activate MMPs, which locally degrade collagen and gelatine. Women have relaxin receptors in multiple joints including the hip and knee, and increased relaxin correlates with increased musculoskeletal injuries. Relaxin has paracrine effects in the female pelvis on ligaments adjacent to hip structures, such as acetabular labral cells which express high levels of relaxin-targeted MMPs. Therefore, it is imperative to investigate the effect of relaxin on the hip to determine if increased levels of relaxin are associated with an increased risk of acetabular labral tears.
Keywords: female reproductive cycle; hip preservation; hormonal contraceptives; menstrual cycle hormones; relaxin; sex differences; sex-based.
Copyright © 2022 Parker, Meyer, Goetz, Willey and Westermann.
Conflict of interest statement
All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare as follows: MW reports personal fees from Depuy Synthes Sales Inc, other from Smith & Nephew, personal fees from Zimmer Biomet Inc, personal fees from Stryker Corp; outside the submitted work. RW reports personal fees, non-financial support and other from Smith and Nephew, other from Arthrex, personal fees from Medical Device Business Systems, personal fees from Linvatec Corporation, other from Wardlow Enterprises; outside the submitted work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Weber AE, Nakata H, Mayer EN, Bolia IK, Philippon MJ, Snibbe J, et al. Return to Sport After Hip Arthroscopy for Femoroacetabular Impingement Syndrome in NCAA Division I Athletes: Experience at a Single Institution. Orthop J Sports Med (2020) 8(5):2325967120918383. doi: 10.1177/2325967120918383 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
